13.10

5.48% 0.68

Oric Pharmaceuticals Inc (ORIC)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$12.42

Offen:

$12.58

24-Stunden-Volumen:

1.46M

Relative Volume:

1.09

Marktkapitalisierung:

$1.27B

Einnahmen:

Nettoeinkommen (Verlust:

$-137.25M

KGV:

-6.9312

EPS:

-1.89

Netto-Cashflow:

$-121.97M

1W Leistung:

+2.50%

1M Leistung:

+25.24%

6M Leistung:

+152.41%

1J Leistung:

+55.21%

1-Tages-Spanne:

$12.47

$13.38

1-Wochen-Bereich:

$11.71

$13.38

52-Wochen-Spanne:

$3.8951

$14.93

Oric Pharmaceuticals Inc Stock (ORIC) Company Profile

Firmenname

Oric Pharmaceuticals Inc

Sektor

Healthcare (1140)

Branche

Biotechnology (637)

Telefon

(650) 388-5600

Adresse

240 E. GRAND AVE., SOUTH SAN FRANCISCO, CA

Mitarbeiter

128

Twitter

Nächster Verdiensttermin

2024-11-04

Neueste SEC-Einreichungen

ORIC's Discussions on Twitter

Vergleichen Sie ORIC mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ORIC Oric Pharmaceuticals Inc	13.10	1.21B	0	-137.25M	-121.97M	-1.89
VRTX Vertex Pharmaceuticals Inc	421.39	108.36B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	463.43	60.82B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	577.95	61.02B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	817.32	50.01B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	310.81	34.05B	4.56B	-176.77M	225.30M	-1.7177

Oric Pharmaceuticals Inc Stock (ORIC) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-09-04	Fortgesetzt	Guggenheim	Buy
2025-07-08	Eingeleitet	Ladenburg Thalmann	Buy
2024-10-31	Eingeleitet	Wells Fargo	Overweight
2024-09-06	Eingeleitet	Stifel	Buy
2024-02-23	Eingeleitet	Cantor Fitzgerald	Overweight
2023-09-22	Eingeleitet	Wedbush	Outperform
2023-03-23	Hochstufung	H.C. Wainwright	Neutral → Buy
2023-03-21	Hochstufung	Guggenheim	Neutral → Buy
2023-03-16	Hochstufung	Oppenheimer	Perform → Outperform
2022-07-18	Fortgesetzt	Oppenheimer	Perform
2022-04-04	Hochstufung	Citigroup	Neutral → Buy
2022-03-25	Herabstufung	H.C. Wainwright	Buy → Neutral
2022-03-22	Herabstufung	Citigroup	Buy → Neutral
2022-03-22	Herabstufung	Guggenheim	Buy → Neutral
2022-03-22	Herabstufung	Oppenheimer	Outperform → Perform
2021-07-06	Hochstufung	Citigroup	Neutral → Buy
2021-01-25	Herabstufung	Citigroup	Buy → Neutral
2020-08-13	Eingeleitet	Robert W. Baird	Outperform
2020-08-06	Hochstufung	Citigroup	Neutral → Buy
2020-08-03	Eingeleitet	H.C. Wainwright	Buy
2020-05-19	Eingeleitet	Citigroup	Neutral
2020-05-19	Eingeleitet	Guggenheim	Buy
2020-05-19	Eingeleitet	JP Morgan	Overweight
2020-05-19	Eingeleitet	Jefferies	Buy

Alle ansehen

Oric Pharmaceuticals Inc Aktie (ORIC) Neueste Nachrichten

04:46 AM

Oric Pharmaceuticals' (ORIC) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat

04:46 AM

04:16 AM

Will ORIC Pharmaceuticals Inc. stock split again soonTrade Analysis Report & Reliable Entry Point Trade Alerts - newser.com

04:16 AM

01:35 AM

What technical models suggest about ORIC Pharmaceuticals Inc.’s comebackJuly 2025 Sector Moves & Weekly Market Pulse Updates - newser.com

01:35 AM

01:25 AM

Why ORIC Pharmaceuticals Inc. (4TZ) stock stays on top picksTrade Analysis Summary & Weekly Top Performers Watchlists - newser.com

01:25 AM

Oct 25, 2025

Has ORIC Pharmaceuticals Inc. found a price floorJuly 2025 Setups & Technical Confirmation Trade Alerts - newser.com

Oct 25, 2025

Relative strength of ORIC Pharmaceuticals Inc. in sector analysisWeekly Gains Summary & AI Forecast for Swing Trade Picks - newser.com

Oct 25, 2025

Sentiment analysis tools applied to ORIC Pharmaceuticals Inc.July 2025 Retail & Risk Controlled Stock Pick Alerts - newser.com

Oct 25, 2025

How to read the order book for ORIC Pharmaceuticals Inc.July 2025 Review & Real-Time Chart Breakout Alerts - newser.com

Oct 25, 2025

Can you recover from losses in ORIC Pharmaceuticals Inc.2025 Breakouts & Breakdowns & Community Shared Stock Ideas - newser.com

Oct 25, 2025

Oct 24, 2025